Short Interest in BGM Group Ltd. (NASDAQ:BGM) Increases By 76.3%

BGM Group Ltd. (NASDAQ:BGM) saw a large increase in short interest in July. As of July 15th, there was short interest totaling 314,375 shares, an increase of 76.3% from the June 30th total of 178,275 shares. Approximately 0.8% of the company’s stock are sold short. Based on an average daily volume of 748,276 shares, the short-interest ratio is presently 0.4 days.

Hedge Funds Weigh In On BGM Group

Hedge funds have recently bought and sold shares of the business. Marshall Wace LLP bought a new position in BGM Group during the 2nd quarter valued at about $218,000. Mariner LLC bought a new stake in shares of BGM Group in the third quarter worth approximately $267,000. Finally, Geode Capital Management LLC purchased a new position in shares of BGM Group during the second quarter valued at approximately $412,000.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of BGM Group in a research report on Monday, April 20th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, BGM Group has an average rating of “Sell”.

BGM Group Stock Performance

BGM stock traded down $0.02 during midday trading on Thursday, hitting $0.27. The company’s stock had a trading volume of 7,265 shares, compared to its average volume of 303,612. BGM Group has a 12 month low of $0.25 and a 12 month high of $11.80. The firm’s 50-day moving average is $0.33 and its 200-day moving average is $0.91.

BGM Group (NASDAQ:BGM) last issued its earnings results on Tuesday, July 21st. The company reported ($0.08) EPS for the quarter. The business had revenue of $11.80 million during the quarter.

BGM Group Company Profile

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.